Canada markets closed

PolarityTE, Inc. (PTE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5200+0.0700 (+4.83%)
At close: 04:00PM EDT
1.5300 +0.01 (+0.66%)
After hours: 07:45PM EDT
Sign in to post a message.
  • J
    JH
    Hey S 4 BIO, FDA cannot give PTE the SoC, doctors and the health insurance companies decide what is the standard of care.
  • x
    x
    This is my DD, they have close to 90 million shares fully diluted outstanding shares after the reverse split and they will need more cash as it will take 3 to 4 years to complete their BLA.
  • Q
    Quenton
    $8M deal is an absurd sign of the times to keep PTE on life support. If you put the deal in pre-25:1 RS perspective the deal dilutes the capital by almost 159 million shares which includes those investment options. Imagine that.
  • J
    James
    after the dilution I think the company is worth .45 cents but may well fall in value to pennies a share if more money is needed during the next 3 years. It's worthless if it doesn't execute. I shorted it a few times on its big collapse. Still think the technology might have promise.
  • b
    brian
    Is this thing dead?
  • Q
    Quenton
    It looks like that they could not close the deal and revised the offering. Proceeds proposed appear to be slightly south of $4 million. Correct me if I’m missing something.

    https://www.sec.gov/Archives/edgar/data/0001076682/000149315222016093/form424b5.htm
  • d
    dave
    This company is bankrupt. Voting for the rs was the worst that stockholders did. You have all lost your money. Rs is a sure sign that a company is on life support.
  • O
    Outsider
    Analyst Forecast
    According to 7 analysts, the average rating for PTE stock is "Buy." The 12-month stock price forecast is 24.23, which is an increase of 955.77% from the latest price.
    Price Target
    $24.23
    (955.77% upside)
    Analyst Consensus: Buy
  • Q
    Quenton
    The FDA guidance for two pivotal studies to support product registration was a death sentence. It took them more than 2 years to complete a botched incomplete phase 2 study. At that rate it would take at least 3 years to finish one of the two required pivotal studies.
  • M
    Mech
    Can’t believe this site just gave me a 43% winner. (http://market-engross.club)
  • D
    Daniel
    I've been in PTE for 6 months, and I remain because at this point what does it matter. Comments below reference an "early pathway to FDA approval."
    That's nonsense. The honest truth is that the company lacks the funds by a huge margin to complete trials and secure approval. The product is promising, and there is a market, but that doesn't mean it'll make it to market.
    Without securing at least 40 million in financing from somewhere this is DOA.
  • S
    S 4 BIO
    The lowlifes that are shorting the stock are going to pay dearly, when the fda gives PTE the SoC for skin repair.
  • S
    S 4 BIO
    8-K today:

    The Company has been advised through a letter from Nasdaq that that it has regained compliance with the Minimum Bid Price Requirement based on the closing bid price for the Company’s common stock during the 10-day trading period beginning May 17, 2022, and that the listing requirement deficiency is closed.
  • L
    LM Family
    What’s the new ticker gonna be?
  • M
    Michael
    tis is not a scam. reverse splits are an honest way to reverse inflation. now looking for a 1 to 100 reverse split.
  • S
    S 4 BIO
    Friday the 13th, couldn't be any better. This is the pathway to early OK from fda - fantastic news.
  • S
    S 4 BIO
    The new placement, yesterday, should be the last of the bad news for the company.. When the fda gives them the SoC for skin repair, you'll wish you had bought a lot more of the stock..
  • T
    Trisha
    The world is Changing every day invest in your
    future today. This was just a movie some years
    ago but today it has come to reality.
    Nothing is impossible, crypto investments has
    changed life and it is still changing life's
  • o
    oliver
    They'll do anything to do an offering. They have low cash. Expect the unexpected
  • J
    John
    With the FDA on board, PTE is on track to fully validate SkinTE ! Huge DFU market !